High-Throughput Screening Identifies PLK1 Inhibition as a Strategy to Potentiate BTK Blockade in Marginal Zone Lymphoma
Alex Zadro, Alberto J. Arribas, Michela Robusto, Stefania Vultaggio, Adrian Andronache, Giovanni Fagà, Kristýna Kupcová, Eleonora Cannas, Filippo Spriano, Giulio Sartori, Luciano Cascione, Chiara Tarantelli, Sara Napoli, Andrea Rinaldi, Davide Rossi, , Francesco Bertoni
This study identifies PLK1 inhibition as a strategy to enhance BTK blockade in MZL by overcoming resistance through transcriptomic and mechanistic analysis.
bioRxiv · Oct 25, 2025 · PreprintCancer Biology